Skip to main content

Study M704

Study name

Munkboel CH 2018

Title

Sertraline suppresses testis and adrenal steroid production and steroidogenic gene expression while increasing LH in plasma of male rats resulting in compensatory hypogonadism

Overall design

The aim of this study was to investigate the possible endocrine disrupting effect of sertraline on sex steroid production in male rats exposed to 3 therapeutically realistic doses of sertraline 1.25, 5, and 20 mg/kg/day. Sprague-Dawley rats were divided into the following 4 groups: (1) control group (n = 12), (2) low dose of sertraline group (sertraline treatment at the dose of 1.25 mg/kg, n = 6), (3) middle dose of sertraline group (sertraline treatment at the dose of 5 mg/kg, n = 6), and (4) high dose of sertraline group (sertraline treatment at the dose of 20 mg/kg, n = 6). Drugs were administered via food once daily for 2 weeks. Testis, adrenals, plasma, and brain samples were to measure steroid productions.

Study Type

Type3;

Data available

Unavailable

Organism

Rat; Sprague-Dawley rat;

Categories of depression

Healthy individuals; Healthy individuals; Healthy individuals;

Criteria for depression

Not reported

Sample size

30

Tissue

Peripheral; Adrenal gland; Adrenal gland;

Peripheral; Testis; Testis;

Peripheral; Blood; Plasma;

Central; Brain; Brain;

Platform

MS-based; LC-MS: 1290 Aglient infinity series system with mass spectrometer (AB SCIEX 4500 QTRAP);

PMID

29850907

DOI

10.1093/toxsci/kfy059

Citation

Munkboel CH, Larsen LW, Weisser JJ, et al. Sertraline suppresses testis and adrenal steroid production and steroidogenic gene expression while increasing LH in plasma of male rats resulting in compensatory hypogonadism. Toxicol Sci. 2018;163(2):609-619.

Metabolite

Androstenedione;

Corticosterone;

Pregnenolone;

Progesterone;

Testosterone;

5-Androstenediol;

Deoxycorticosterone;

17-Hydroxyprogesterone;

Dihydrotestosterone;

17a-Hydroxypregnenolone;

Aldosterone;